Search...
AlloVir Shareholders Approve Merger With Kalaris Therapeutics
I'm PortAI, I can summarize articles.
AlloVir shareholders have approved the company's proposed merger with Kalaris Therapeutics at a special meeting held Wednesday, the companies said the same day. The merger is expected to close "as soon as practicable" and the combined company will be renamed as Kalaris Therapeutics, with "KLRS" as its updated trading symbol on Nasdaq.
AlloVir shareholders have approved the company's proposed merger with Kalaris Therapeutics at a special meeting held Wednesday, the companies said the same day.
The merger is expected to close "as soon as practicable" and the combined company will be renamed as Kalaris Therapeutics, with "KLRS" as its updated trading symbol on Nasdaq.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments